Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XDYNYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XDYNChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
JN.1.18.4NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
JN.1.18.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JN.1.18.4NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
KP.4.1.3NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
KP.4.1.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
KP.4.1.3NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
KS.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
KS.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
KS.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
MM.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
MM.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
MM.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
JN.1.48.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
JN.1.48.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JN.1.48.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
KP.4.2.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
KP.4.2.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
KP.4.2.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
KP.3.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
KP.3.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
KP.3.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
MC.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
MC.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
MC.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
LB.1.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
LB.1.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
LB.1.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
LP.1.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
LP.1.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
LP.1.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
JN.1.50.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
JN.1.50.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JN.1.50.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
MH.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
MH.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
MH.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
LB.1.3.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
LB.1.3.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
LB.1.3.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
LB.1.3.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
LB.1.3.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
LB.1.3.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
KP.3.4NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
KP.3.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
KP.3.4NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
LB.1.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
LB.1.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
LB.1.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used